Jaguar Health, Inc. — Form 8-K
Filed September 24, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 72/100
What the filing says
Jaguar Health exchanged a portion of a promissory note (original principal amount redacted) issued to Streeterville Capital, LLC on November 12, 2025, for an unspecified number of common shares (both amounts blank in filing). The exchange occurred September 23, 2026, with shares issued free-trading and without restrictive legend. The Original Note balance was reduced by the partitioned amount; all other terms remain unchanged.
Why this rating
Debt-to-equity conversion is material for a $3.8M company but lacks critical specifics: dollar amounts and share count are redacted. Suggests refinancing stress and dilution risk, but magnitude unclear relative to company size.
Price action (we called it neutral)
before filing · preread $7.77 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from September 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.